[Histone deacetylase inhibitors--new anticancer agents?].
Yoshida
M
M
Department of Biotechnology, Graduate School of Agriculture and Life Sciences, University of Tokyo, Japan. ayoshida@mail.ecc.u-tokyo.ac.jp
Horinouchi
S
S
D000123:Acetyltransferases / Q000502:physiology; D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D047630:Depsipeptides; D015195:Drug Design; D004791:Enzyme Inhibitors; D051548:Histone Acetyltransferases; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000502:physiology; D006801:Humans; D006877:Hydroxamic Acids; D010455:Peptides; D010456:Peptides, Cyclic; D029701:Saccharomyces cerevisiae Proteins; D014158:Transcription, Genetic; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D047630:Depsipeptides; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D010455:Peptides; D010456:Peptides, Cyclic; D029701:Saccharomyces cerevisiae Proteins; D016159:Tumor Suppressor Protein p53; C067070:trapoxin A; C012589:trichostatin A; C087123:romidepsin; D000123:Acetyltransferases; D051548:Histone Acetyltransferases; D006655:Histone Deacetylases